October 13, 2017
Authored and Edited by Christina Ji-Hye Yang; Lillian R. Phares; Elizabeth D. Ferrill
In In re Arunachalam, No. 2016-1607, the Federal Circuit affirmed the PTAB decision holding that Dr. Lakshmi Arunachalam is collaterally estopped from asserting claims in U.S. Patent No. 6,212,556 (’556 Patent) because a district court had invalidated claims in a related patent, U.S. Patent No. 5,987,500 (’500 Patent).
Both patents are directed to systems and methods for engaging in real-time, two-way transactions over a network. In a prior litigation, the Delaware district court invalidated claims in the ’500 Patent. Meanwhile, the ’556 Patent’s patentability was challenged at the PTAB, which found its claims unpatentable. Dr. Arunachalam appealed the PTAB’s decision.
The Federal Circuit held that Dr. Arunachalam is collaterally estopped from arguing the patentability of challenged claims in the ’556 Patent because she had a full and fair opportunity to litigate their validity and patentability. The Court found that the challenged claims are not materially different from those already invalidated by the Delaware district court or found unpatentable by the PTAB. Furthermore, the Court added that Dr. Arunachalam failed to show a reversible error in the PTAB’s decision affirming the Examiner’s rejection over a prior art reference. Therefore, the Federal Circuit dismissed Dr. Arunachalam’s appeal.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.